Skip to content
Government Federal, Medical Health Aged Care

Safe access to contraception must be a priority

Pharmaceutical Society of Australia (PSA) 2 mins read

26 May 2023

A Senate Committee report into sexual and reproductive healthcare has supported the Pharmaceutical Society of Australia’s (PSA’s) call for pharmacists to play a greater role in improving safe access to contraceptives.

The Report tabled by the Senate Community Affairs Reference Committee, Ending the postcode lottery: Addressing barriers to sexual, maternity and reproductive healthcare in Australia, recommended significant changes to Australia's health system to make contraception, abortion and pregnancy care more accessible.

Among the recommendations are calls for all health professionals to practise to their full scope.

PSA National President Dr Fei Sim FPS acknowledged the recommendations, reiterating her support for pharmacist-prescribed contraceptives.

“Safe access to latest and safest contraception is not a luxury, it is a basic healthcare need,” Dr Sim said.

“Pharmacists are ready and able to improve healthcare for all Australians, offering safe, accessible, and equitable access to contraception and expert advice on their options.

“In many places around the world, pharmacists are already able to prescribe contraceptives to patients, giving us a model of care that is improving healthcare access for patients.

“To ensure that access to reproductive healthcare is timely and contemporary we must be prepared to do things differently and allow all health professionals to practice to their top of scope.

“Oral contraceptive pills are widely considered to be safe and effective medications, with more than 100 countries around the world allowing pharmacists to prescribe them without a prescription.

“Pharmacists are well placed to inform patients about their contraceptive options, including Long Acting Reversible Contraceptives.

“This is about making sure that Australians can access contraception when and where they need it.

“Pharmacists can and should be doing more to support the healthcare needs of Australians,” Dr Sim concluded. 


About us:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

 


Contact details:

Georgia Clarke   M: 0480 099 798  E: [email protected]

 

More from this category

  • Medical Health Aged Care
  • 09/12/2025
  • 05:30
Centre for Eye Research Australia

Australian scientists reveal new genetic risk for severe macular degeneration

Researchers and a person living with macular degeneration are available for interview in East Melbourne today. Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD). A new study, published today inNature Communications, reveals the specific genetic factors linked to the presence of reticular pseudodrusen - deposits which drive vision loss and are found on the retina of up to 60 per cent of people with advanced AMD. The research, led by the Centre for Eye Research Australia, WEHI and the University of Melbourne, offers a…

  • Medical Health Aged Care
  • 09/12/2025
  • 01:11
SoluPet Inc.

SoluPet Inc. (SoluPet) Announces Strategic Partnership with CHC Healthcare Group (CHC) to Advance Canine Cognitive Health in Asia

Partnership with CHC in Taiwan will pilot SoluPet’s flagship Neuronal Defense™ formulation through CHC’s veterinary and consumer-health ecosystem TORONTO–BUSINESS WIRE– SoluPet,the data and science-driven…

  • Contains:
  • Medical Health Aged Care
  • 09/12/2025
  • 00:11
AdvanCell

AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies

Thorium-228 (228Th) is the parent isotope and key starting material to produce the alpha-emitter Lead-212 (212Pb) The established capability to receive and process high-activity…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.